Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

PTEN reduces endosomal PtdIns(4,5)P2 in a phosphatase-independent manner via a PLC pathway.

Mondin VE, Ben El Kadhi K, Cauvin C, Jackson-Crawford A, Bélanger E, Decelle B, Salomon R, Lowe M, Echard A, Carréno S.

J Cell Biol. 2019 Jul 1;218(7):2198-2214. doi: 10.1083/jcb.201805155. Epub 2019 May 22.

PMID:
31118240
2.

Murine Bone Marrow Mesenchymal Stromal Cells Respond Efficiently to Oxidative Stress Despite the Low Level of Heme Oxygenases 1 and 2.

Nowak WN, Taha H, Kachamakova-Trojanowska N, Stępniewski J, Markiewicz JA, Kusienicka A, Szade K, Szade A, Bukowska-Strakova K, Hajduk K, Klóska D, Kopacz A, Grochot-Przęczek A, Barthenheier K, Cauvin C, Dulak J, Józkowicz A.

Antioxid Redox Signal. 2018 Jul 10;29(2):111-127. doi: 10.1089/ars.2017.7097. Epub 2018 Jan 3.

3.

SUMOylation of human septins is critical for septin filament bundling and cytokinesis.

Ribet D, Boscaini S, Cauvin C, Siguier M, Mostowy S, Echard A, Cossart P.

J Cell Biol. 2017 Dec 4;216(12):4041-4052. doi: 10.1083/jcb.201703096. Epub 2017 Oct 19.

4.

Rab35 GTPase Triggers Switch-like Recruitment of the Lowe Syndrome Lipid Phosphatase OCRL on Newborn Endosomes.

Cauvin C, Rosendale M, Gupta-Rossi N, Rocancourt M, Larraufie P, Salomon R, Perrais D, Echard A.

Curr Biol. 2016 Jan 11;26(1):120-8. doi: 10.1016/j.cub.2015.11.040. Epub 2015 Dec 24.

5.

Phosphoinositides: Lipids with informative heads and mastermind functions in cell division.

Cauvin C, Echard A.

Biochim Biophys Acta. 2015 Jun;1851(6):832-43. doi: 10.1016/j.bbalip.2014.10.013. Epub 2014 Nov 4. Review.

PMID:
25449648
6.

Long-term survivors after surgical management of metastatic spinal cord compression.

Tabouret E, Gravis G, Cauvin C, Loundou A, Adetchessi T, Fuentes S.

Eur Spine J. 2015 Jan;24(1):209-15. doi: 10.1007/s00586-014-3676-1. Epub 2014 Nov 19.

PMID:
25408254
7.

Reassessment of scoring systems and prognostic factors for metastatic spinal cord compression.

Tabouret E, Cauvin C, Fuentes S, Esterni B, Adetchessi T, Salem N, Madroszyk A, Gonçalves A, Casalonga F, Gravis G.

Spine J. 2015 May 1;15(5):944-50. doi: 10.1016/j.spinee.2013.06.036. Epub 2013 Oct 9.

PMID:
24120144
8.

Aurora B and cyclin B have opposite effects on the timing of cytokinesis abscission in Drosophila germ cells and in vertebrate somatic cells.

Mathieu J, Cauvin C, Moch C, Radford SJ, Sampaio P, Perdigoto CN, Schweisguth F, Bardin AJ, Sunkel CE, McKim K, Echard A, Huynh JR.

Dev Cell. 2013 Aug 12;26(3):250-65. doi: 10.1016/j.devcel.2013.07.005.

9.

Cognitive barriers to readiness to change in alcohol-dependent patients.

Le Berre AP, Vabret F, Cauvin C, Pinon K, Allain P, Pitel AL, Eustache F, Beaunieux H.

Alcohol Clin Exp Res. 2012 Sep;36(9):1542-9. doi: 10.1111/j.1530-0277.2012.01760.x. Epub 2012 Mar 28.

10.

Primary leiomyosarcoma of the seminal vesicle: case report and review of the literature.

Cauvin C, Moureau-Zabotto L, Chetaille B, Hilgers W, Denoux Y, Jacquemier J, Guiramand J, Sarran A, Bertucci F.

BMC Cancer. 2011 Jul 29;11:323. doi: 10.1186/1471-2407-11-323. Review.

11.

Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.

Vandurm P, Guiguen A, Cauvin C, Georges B, Le Van K, Michaux C, Cardona C, Mbemba G, Mouscadet JF, Hevesi L, Van Lint C, Wouters J.

Eur J Med Chem. 2011 May;46(5):1749-56. doi: 10.1016/j.ejmech.2011.02.028. Epub 2011 Feb 22.

PMID:
21385662
12.

Structural and theoretical studies of [6-bromo-1-(4-fluorophenylmethyl)-4(1H)-quinolinon-3-yl)]-4-hydroxy-2-oxo-3-butenoïc acid as HIV-1 integrase inhibitor.

Vandurm P, Cauvin C, Guiguen A, Georges B, Le Van K, Martinelli V, Cardona C, Mbemba G, Mouscadet JF, Hevesi L, Van Lint C, Wouters J.

Bioorg Med Chem Lett. 2009 Aug 15;19(16):4806-9. doi: 10.1016/j.bmcl.2009.06.044. Epub 2009 Jun 14.

PMID:
19556126
13.

New pyridinone derivatives as potent HIV-1 nonnucleoside reverse transcriptase inhibitors.

Le Van K, Cauvin C, de Walque S, Georges B, Boland S, Martinelli V, Demonté D, Durant F, Hevesi L, Van Lint C.

J Med Chem. 2009 Jun 25;52(12):3636-43. doi: 10.1021/jm801438e.

PMID:
19469474
14.

Comparison of 3D structures and AT(1) binding properties of pyrazolidine-3,5-diones and tetrahydropyridazine-3,6-diones with parent antihypertensive drug irbesartan.

Le Bourdonnec B, Cauvin C, Meulon E, Yous S, Goossens JF, Durant F, Houssin R, Hénichart JP.

J Med Chem. 2002 Oct 10;45(21):4794-8.

PMID:
12361407
15.

Pyrazolidine-3,5-dione angiotensin-II receptor antagonists.

Cauvin C, Le Bourdonnec B, Norberg B, Hénichart JP, Durant F.

Acta Crystallogr C. 2001 Nov;57(Pt 11):1330-2. Epub 2001 Nov 13.

PMID:
11706265
16.

Effects of oxodipine on isolated rabbit aorta and mesenteric resistance vessels.

Tejerina T, Cauvin C, Tamargo J.

Eur J Pharmacol. 1992 Aug 25;219(2):279-84.

PMID:
1425952
17.

Differential blockade of agonist- and depolarization-induced 45Ca2+ influx in smooth muscle cells.

Wallnöfer A, Cauvin C, Lategan TW, Rüegg UT.

Am J Physiol. 1989 Oct;257(4 Pt 1):C607-11.

PMID:
2679123
18.

Receptor-operated calcium-permeable channels in vascular smooth muscle.

Rüegg UT, Wallnöfer A, Weir S, Cauvin C.

J Cardiovasc Pharmacol. 1989;14 Suppl 6:S49-58.

PMID:
2478825
19.

The mechanism of action of endothelin-1 as compared with other agonists in vascular smooth muscle.

Wallnöfer A, Weir S, Rüegg U, Cauvin C.

J Cardiovasc Pharmacol. 1989;13 Suppl 5:S23-31; discussion S45.

PMID:
2473323
20.

The effects of Ca2+ antagonists on isolated rat and rabbit mesenteric resistance vessels. What determines the sensitivity of agonist-activated vessels to Ca2+ antagonists?

Cauvin C, Tejerina M, Hwang O, Kai-Yamamoto M, van Breemen C.

Ann N Y Acad Sci. 1988;522:338-50. No abstract available.

PMID:
3377371
21.

Agonist-induced activation of rat mesenteric resistance vessels: comparison between noradrenaline and vasopressin.

Cauvin C, Weir SW, Wallnöfer A, Rüegg U.

J Cardiovasc Pharmacol. 1988;12 Suppl 5:S128-33.

PMID:
2469870
22.
23.

Do calcium antagonists correct a pathophysiological abnormality in hypertension?

Bühler FR, Cauvin C, Blaustein MP, Hermsmeyer K, Robinson BF.

J Cardiovasc Pharmacol. 1988;12 Suppl 6:S1-2. Review. No abstract available.

PMID:
2468886
24.

Effects of atriopeptin III on isolated mesenteric resistance vessels from SHR and WKY.

Cauvin C, Tejerina M, van Breemen C.

Am J Physiol. 1987 Dec;253(6 Pt 2):H1612-7.

PMID:
2962508
25.

Vasopressin increases 45Ca2+ influx in rat aortic smooth muscle cells.

Wallnöfer A, Cauvin C, Rüegg UT.

Biochem Biophys Res Commun. 1987 Oct 14;148(1):273-8.

PMID:
3675578
26.
27.

Vascular smooth muscle calcium channels.

van Breemen C, Cauvin C, Yamamoto H, Zschauer A.

J Cardiovasc Pharmacol. 1987;10 Suppl 10:S10-6. Review.

PMID:
2455103
28.

45Ca fluxes in rat mesenteric resistance vessels.

Cauvin C, Gelband C, van Breemen C.

J Cardiovasc Pharmacol. 1987;10 Suppl 1:S44-8.

PMID:
2442517
29.

Ca2+ regulation of vascular smooth muscle.

Van Breemen C, Cauvin C, Johns A, Leijten P, Yamamoto H.

Fed Proc. 1986 Nov;45(12):2746-51. Review.

PMID:
2429876
30.

Calcium activation of vascular smooth muscle. State of the art lecture.

van Breemen C, Leijten P, Yamamoto H, Aaronson P, Cauvin C.

Hypertension. 1986 Jun;8(6 Pt 2):II89-95. Review.

PMID:
2424835
31.

Regulation of cytoplasmic Ca2+ in vascular smooth muscle.

van Breemen C, Cauvin C, Leyten P, Lodge N, Saida K.

Prog Clin Biol Res. 1986;219:157-68. Review.

PMID:
2431414
32.
33.

Ca2+ sources mobilized by alpha 1-receptor activation in vascular smooth muscle.

Leijten P, Cauvin C, Lodge N, Saida K, Van Breemen C.

Clin Sci (Lond). 1985;68 Suppl 10:47s-50s.

PMID:
2857619
34.

Different Ca2+ channels along the arterial tree.

Cauvin C, van Breemen C.

J Cardiovasc Pharmacol. 1985;7 Suppl 4:S4-10.

PMID:
2412011
35.

Regulation of Ca2+ levels in smooth-muscle cells.

Cauvin C, van Breemen C.

Biochem Soc Trans. 1984 Dec;12(6):939-41. No abstract available.

PMID:
6099290
36.

A theoretic consideration on the use of calcium antagonists in the treatment of hypertension.

Van Breemen C, Lukeman S, Cauvin C.

Am J Med. 1984 Oct 5;77(4A):26-30.

PMID:
6091448
38.
39.

Theoretical bases for vascular selectivity of Ca2+ antagonists.

Cauvin C, Lukeman S, Cameron J, Hwang O, Meisheri K, Yamamoto H, van Breemen C.

J Cardiovasc Pharmacol. 1984;6 Suppl 4:S630-8.

PMID:
6083405
40.
41.

Mechanisms of calcium antagonist-induced vasodilation.

Cauvin C, Loutzenhiser R, Van Breemen C.

Annu Rev Pharmacol Toxicol. 1983;23:373-96. Review. No abstract available.

PMID:
6307126
42.

Alpha 1-adrenoceptors induce Ca influx and intracellular Ca release in isolated rabbit aorta.

Cauvin C, Loutzenhiser R, Hwang O, Van Breemen C.

Eur J Pharmacol. 1982 Oct 22;84(3-4):233-5. No abstract available.

PMID:
6293850
43.

Effect of reserpine on relaxant responses of canine femoral arterial strips.

Cauvin CA, Devia CJ, Kirkendol PL.

Clin Exp Pharmacol Physiol. 1982 Sep-Oct;9(5):511-4.

PMID:
6814801
44.
45.

Effects of Ca antagonists on Ca fluxes in resistance vessels.

Cauvin C, Saida K, van Breemen C.

J Cardiovasc Pharmacol. 1982;4 Suppl 3:S287-90.

PMID:
6184554
46.

Effect of reserpine pretreatment on in vivo femoral arterial responses to vasodilator agents.

Cauvin CA, Devia CJ, Kirkendol PL.

J Pharmacol Exp Ther. 1981 Mar;216(3):447-52.

PMID:
6782236
47.

The hypotensive response to compound 48/80 in normotensive and hypertensive rats.

Kirkendol PL, Cauvin CA.

Clin Exp Pharmacol Physiol. 1980 Nov;7(6):635-8.

PMID:
6166418
48.

Tooth pulp pressure: local and systemic influences of epinephrine and acetylcholine.

Cauvin CA, Kirkendol PL.

Pharmacol Ther Dent. 1980;5(1-2):17-24.

PMID:
6932047

Supplemental Content

Loading ...
Support Center